
FDA Companion Diagnostic Drug Label Crosswalk Matrix
A 2026 FDA companion diagnostic drug label crosswalk with seven selected relationships, specimen and biomarker requirements, PMA supplements, label-version gaps, and a machine-readable data dictionary.